Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats

Behavioural Brain Research

Volumn 156, Issue 1, 2005, Pages 1-10

  Van Der Staay, F Josef ^a,b   Bouger, Pascale C ^a  

^a BAYER AG   (Germany)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Animal model; Cone field; E2020; Metrifonate; Rat; Scopolamine; Spatial memory; Strategy

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; METRIFONATE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RAT; LATENT PERIOD; MALE; MEASUREMENT; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SCREENING; SPATIAL ORIENTATION; TASK PERFORMANCE; VELOCITY; WORKING MEMORY;

ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; INDANS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; MOTIVATION; MOTOR ACTIVITY; NOOTROPIC AGENTS; ORIENTATION; PIPERIDINES; RATS; RATS, WISTAR; REACTION TIME; SCOPOLAMINE; SPACE PERCEPTION; TRICHLORFON;

EID: 4944254557     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.05.010     Document Type: Article

References (73)

1. Y. Abe, A. Aoyagi, T. Hara, K. Abe, R. Yamazaki, and Y. Kumagae Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease J. Pharmacol. Sci. 93 2003 95 105
2. C.A. Barnes Aging and the physiology of spatial memory Neurobiol. Aging 9 1988 563 568
3. C.A. Barnes, J. Meltzer, F. Houston, G. Orr, K. McGann, and G.L. Wenk Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors Neuroscience 99 2000 17 23
4. R.T. Bartus, R.L. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 210 1982 408 417
5. R.T. Bartus On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis Exp. Neurol. 163 2000 495 529
6. A. Blokland, W. Raaijmakers, W. Honig, and F.J. van der Staay Spatial discrimination learning and orientation strategy in young and old Lewis rats Neurosci. Res. Commun. 10 1992 105 110
7. A. Blokland, and W. Raaijmakers Age-related changes in correlation between behavioral and biochemical parameters in Lewis rats Behav. Neural Biol. 60 1993 52 61
8. A. Blokland, V.C. Hinz, and B.H. Schmidt Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: evaluation of the efficacy/safety profile in rats Drug Dev. Res. 36 1995 166 179
9. A. Blokland, W. Honig, and J. Prickaerts Effects of haloperidol and d-amphetamine on working and reference memory performance in a spatial cone field task Behav. Pharmacol. 9 1998 429 436
10. A. Blokland, L.M. Broersen, Uylings HBM, and J. Jolles Intact spatial discrimination performance but impaired reaction time performance after frontal cortex lesions in the rat Neurosci. Res. Commun. 33 1 2003 1 16
11. R. Bullock The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: a hypothesis Int. J. Clin. Pract. 56 2002 206 214
12. D.T. Campbell, and D.W. Fiske Convergent and discriminant validation by the multitrait-multimethod matrix Psychol. Bull. 56 1955 81 105
13. Z. Chen, A.J. Xu, R. Li, and E.Q. Wei Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147 Acta Pharmacol. Sin. 23 2002 355 360
14. D.H. Cheng, H. Ren, and X.C. Tang Huperzine A, a novel promising acetylcholinesterase inhibitor NeuroReport 8 1996 97 101
15. D.H. Cheng, and X.C. Tang Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities Pharmacol. Biochem. Behav. 60 1998 377 386
16. F. Coelho, and J. Birks Physostigmine for Alzheimer's disease Cochrane Database Syst. Rev. 2003 2
17. J.W. Cotton Analyzing within-subjects experiments 1998 Lawrence Erlbaum Associates Mahwah, New Jersey
18. J.L. Cummings Alzheimer's disease: from molecular biology to neuropsychiatry Semin. Clin. Neuropsychiatry 8 2003 31 36
19. S. Dachir, B. Schmidt, and A. Levy Effects of metrifonate on radial arm maze acquisition in middle-age rats Brain Res. 777 1997 251 254
20. S. Darvesh, C. MacKnight, and K. Rockwood Butyrylcholinesterase and cognitive function Int. Psychogeriatry 13 2001 461 464
21. S. Gauthier Alzheimer's disease: current and future therapeutics perspective Prog. Neuropsychopharmacol. Biol. Psychiatry 25 2001 73 89
22. E. Giacobini Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease? CNS Drugs 15 2001 85 91
23. E. Giacobini, R. Spiegel, A. Enz, A.E. Veroff, and N.R. Cutler Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit J. Neural Transm. 109 2002 1053 1065
24. J. Grutzendler, and J.C. Morris Cholinesterase inhibitors for Alzheimer's disease Drugs 61 2001 41 52
25. V.C. Hinz, A. Blokland, F.J. van der Staay, I. Gebert, T. Schuurman, and B.H. Schmidt Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents Drug Dev. Res. 38 1996 31 42
26. V.C. Hinz, S. Grewig, and B.H. Schmidt Metrifonate and dichlorvos: effects of a singe oral administration on cholinesterase activity in rat brain and blood Neurochem. Res. 21 1996 339 345
27. A. Itoh, A. Nitta, Y. Katono, M. Usui, K. Naruhashi, and R. Iida Effects of metrifonate on memory impairment and cholinergic dysfunction in rats Eur. J. Pharmacol. 322 1997 11 19
28. D.L.D. Kirkby, D.N.D. Jones, J.C.J. Barnes, and G.A.G. Higgins Effects of anticholinesterase drugs tacrine and E2020 the 5-HT(3) antagonist ondansetron and the H(3) antagonist thioperamide in models of cognition and cholinergic function Behav. Pharmacol. 7 1996 513 525
29. M.A. Kronforst-Collins, P.L. Moriearty, M. Ralph, R.E. Becker, B. Schmidt, and L.T. Thompson Metrifonate treatment enhances acquisition of eye-blinking conditioning in aging rabbits Pharmacol. Biochem. Behav. 56 1997 103 110
30. M.A. Kronforst-Collins, P.L. Moriearty, B. Schmist, and J.F. Disterhoft Metrifonate improves associative learning and retention in aging rabbits Behav. Neurosci. 111 1997 1031 1040
31. J. Laszy, and I. Gyertyan Effects of memory enhancer compounds on the learning performance of rats in the water-labyrinth test Fundam. Clin. Pharmacol. 15 2001 35
32. O. Lehmann, A.J. Grottick, J.C. Cassel, and G.A. Higgins A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and/or the septal region Eur. J. Neurosci. 18 2003 651 666
33. L. Liu, L. Gauthier, and S. Gauthier Spatial disorientation in persons with early senile dementia of the Alzheimer type Am. J. Occup. Ther. 45 1991 67 74
34. M.P. McDonald, and J.B. Overmier Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease Neurosci. Biobehav. Rev. 22 1998 99 120
35. M. Mesulam, A. Guillozet, P. Shaw, and B. Quinn Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain Neurobiol. Dis. 9 2002 88 93
36. S.E. Molchan, R.A. Martinez, J.L. Hill, H.J. Weingartner, K. Thompson, and B. Vitiello Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model Brain Res. Rev. 17 1991 215 226
37. R.G.M. Morris Development of a water-maze procedure for studying spatial learning in the rat J. Neurosci. Methods 11 1984 47 60
38. W.R. Mundy, S. Barone, and H.A. Tilson Neurotoxic lesions of the nucleus basalis induced by colchicine: effects on spatial navigation in the water maze Brain Res. 512 1990 221 228
39. T. Nabeshima, A. Nitta, A. Itoh, Y. Katono, and N. Hasegawa Effects of metrifonate on impairment of learning, memory and acetylcholine released induced by scopolamine and basal forebrain lesion in rats Book of the 55th World Congress of Pharmacy and Pharmaceutical Science Stockholm, 28 August-September 1995 [Abstract]
40. L. Nobili, and W.G. Sannita Cholinergic modulation, visual function and Alzheimer's disease Vision Res. 37 1997 3559 3571
41. A. Nordberg, and A.L. Svensson Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology Drug Saf. 19 1998 465 480
42. H. Ogura, T. Kosasa, S. Araki, Y. Yamanishi, K. Yamatsu, and A.E. Tsukub E2020, a novel centrally acting acetylcholinesterase inhibitor (3): behavioral study of cholinergic action in rats Jpn. J. Pharmacol. 49 Suppl. 1989 155P
43. H. Ogura, T. Kosasa, Y. Kuriya, and Y. Yamanishi Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats Methods Find. Exp. Clin. Pharmacol. 22 2000 89 95
44. D.S. Olton, and R.J. Samuelson Remembrance of places passed: spatial memory in rats J. Exp. Psychol. Anim. Behav. Process. 2 1976 97 116
45. D.S. Olton, and B.C. Papas Spatial memory and hippocampal function Neuropsychologia 17 1979 669 682
46. G. Pacheco, R. Palacios-Esquivel, and D.E. Moss Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase J. Pharmacol. Exp. Ther. 274 1995 767 770
47. S.J. Prickaerts, W. Honig, B.H. Schmidt, and A. Blokland Metrifonate improves working but not reference memory performance in a spatial cone field task Eur. J. Pharmacol. 380 1999 61 65
48. G. Poorheidari, K.J. Stanhope, and J.A. Pratt Effects of the potassium channel blocker apamin and 4-aminopyridine on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020 Psychopharmacology 135 1998 242 255
49. Raaijmakers WGM, van Nies JHM, and F.J. van der Staay Behavioural effects of chronic dietary lecithin supplementation in adult and aged rats C.F.A. van Bezooijen R. Ravid A.A.J. Verhofstad From gene to man 1990 Stichting Gerontologie en Geriatrie Rijswijk 164 168
50. P. Richards, M. Johnson, D.E. Ray, and C. Walker Novel protein targets for organophosphorous compounds Chem. Biol. Interact. 1999 503 511
51. P.G. Richards, M.K. Johnson, and D.E. Ray Identification of acetylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs Mol. Pharmacol. 58 2000 577 583
52. P. Riekkinen, B. Schmidt, R. Stefanski, J. Kuitunen, and M. Riekkinen Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats Eur. J. Pharmacol. 309 1996 121 130
53. P. Riekkinen, B. Schmidt, and M. Riekkinen Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats Eur. J. Pharmacol. 323 1997 11 19
54. T.W. Robbins Homology in behavioural pharmacology: an approach to animal models of human cognition Behav. Pharmacol. 9 1998 509 519
55. D.C. Rogers, and J.J. Hagan 5-HT6 receptor antagonists enhance retention of a water maze task in the rat Psychopharmacology 158 2001 114 119
56. S.L. Rogers, Y. Yamanishi, and K. Yamatsu E2020: the pharmacology of a piperidine cholinesterase inhibitor R. Becker E. Giacobini Advances in Alzheimer disease therapy series: cholinergic basis for Alzheimer therapy 1991 Birkhaeuser Boston Cambridge, MA 314 320
57. C. Scali, M.G. Giovannini, L. Bartolini, C. Propsperi, V. Hinz, and B. Schmidt Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats Eur. J. Pharmacol. 325 1997 173 180
58. B. Schmidt, V.C. Hinz, and F.J. van der Staay The preclinical pharmacology of metrifonate, a long-acting and well tolerated cholinesterase inhibitor for Alzheimer therapy A. Fisher I. Hanin M. Yoshida Progress in Alzheimer's and Parkinson's diseases Advances in behavioral biology vol. 49 1998 Plenum Press New York 579 585
59. M.F. Snape, A. Misra, T.K. Murray, R.J. De Souza, J.L. Williams, and A.J. Cross A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066 Neuropharmacology 38 1999 181 193
60. T. Steckler, and J.L. Muir Measurement of cognitive function: relating rodent performance with human minds. Brain Res. Cogn. 3 1996 299 308
61. F.J. van der Staay Spatial working and reference memory of Brown Norway and WAG rats in a holeboard discrimination task Neurobiol. Learn. Mem. 71 1999 113 125
62. F.J. van der Staay, W.G. Raaijmakers, A.J. Lammers, and J.A. Tonnaer Selective fimbria lesions impair acquisition of working and reference memory of rats in a complex spatial discrimination task Behav. Brain Res. 32 1989 151 161
63. F.J. van der Staay, A. Blokland, and W. Raaijmakers Different time course for age-related changes of behavior in a complex spatial cone-field discrimination task in Lewis rats Psychobiology 18 1990 305 311
64. F.J. van der Staay, B. Krechting, A. Blokland, and W. Raaijmakers The cone field: a spatial discrimination task for the automatic and simultaneous assessment of working and reference memory in rats J. Neurosci. Methods 31 1990 13 22
65. F.J. van der Staay, J. van Nies, and WG.M. Raaijmakers The effects of aging in rats on working and reference memory performance in a spatial holeboard discrimination task Behav. Neural Biol. 53 1990 356 370
66. F.J. van der Staay, V.C. Hinz, and B.H. Schmidt Effects of metrifonate, its transformation product dichlorvos and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats J. Pharmacol. Exp. Ther. 278 1996 697 708
67. F.J. van der Staay, V.C. Hinz, and B.H. Schmidt Effects of metrifonate on escape and avoidance learning in young and aged rats Behav. Pharmacol. 7 1996 56 64
68. van der Staay FJ, Bouger PC. Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance. Submitted for publication.
69. E.L.J.M. van Luijtelaar, F.J. van der Staay, and J.M.L. Kerbusch Spatial memory in rats: a cross validation study Q. J. Exp. Psychol. 41B 1989 287 306
70. E.C. Vliet, J. Manly, M.X. Tang, K. Marder, K. Bell, and Y. Stern The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline J. Int. Neuropsychol. Soc. 9 2003 720 732
71. T. Wang, and X.C. Tang Reversal of scopolamine-induced deficits in radial maze performance by (-)-hyperzine A: comparison with E2020 and tacrine Eur. J. Pharmacol. 349 1998 137 142
72. P.J. Whitehouse Donepezil Drugs Today 34 1998 321 326
73. C. Wolfson, M. Oremus, V. Shukla, F. Momoli, L. Demers, A. Perrault, and Y. Moride Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness Clin. Ther. 24 2002 862 886